Ascentage Pharma Group International (AAPG)
NASDAQ: AAPG · Real-Time Price · USD
26.56
-0.77 (-2.82%)
Apr 8, 2026, 10:31 AM EDT - Market open
AAPG Market Cap
AAPG has a market cap or net worth of $2.4 billion as of April 8, 2026. Its market cap has increased by 48.34% in one year.
Market Cap
2.40B
Enterprise Value
2.33B
1-Year Change
48.34%
Ranking
Category
Stock Price
$26.56
Market Cap Chart
Since the IPO on June 13, 2022, AAPG's market cap has increased from $554.36M to $2.40B, an increase of 332.51%. That is a compound annual growth rate of 46.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 2.44B | -1.06% |
| Dec 31, 2025 | 2.47B | 36.38% |
| Dec 31, 2024 | 1.81B | 82.20% |
| Dec 29, 2023 | 994.30M | 16.90% |
| Dec 30, 2022 | 850.58M | 53.44% |
| Jun 13, 2022 | 554.36M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oruka Therapeutics | 2.64B |
| Kodiak Sciences | 2.51B |
| Disc Medicine | 2.49B |
| Immunome | 2.47B |
| Beam Therapeutics | 2.45B |
| Sarepta Therapeutics | 2.44B |
| Veradermics | 2.40B |
| Celldex Therapeutics | 2.39B |